Patent Assignment
Reel/Frame 056560/0989
Assignment of Assignor's Interest
Recorded: 2021-06-16
Pages: 4
Assignor
LIECHTI, MATTHIAS EMANUEL
Executed: 2021-06-11
Assignee
UNIVERSITÄTSSPITAL BASEL
RECHTSDIENST, HEBELSTRASSE 32, BASEL, 4031, SWITZERLAND
Covered Properties
(9)
Controlling Effects After 5HT2A Agonists Administration
PCT:
PCT/US2021/014721 ↗
Mdma Treatment to Enhance Acute Emotional Effects Profile of Lsd, Psilocybin or Other Psychedelics
PCT:
PCT/US2021/028707 ↗
Controlling Effects After 5HT2A Agonists Administration
Application:
17/156,233 →
Publication:
US 2021/0267977
Mdma Treatment to Enhance Acute Emotional Effects Profile of Lsd, Psilocybin, or Other Psychedelics
Controlling Effects After 5HT2A Agonists Administration
Application:
62/982,877 →
Mdma Treatment to Enhance Acute Emotional Effects Profile of Lsd, Psilocybin, or Other Psychedelics
Application:
63/020,261 →
Intravenous Dmt Administration Method for Dmt-Assisted Psychotherapy
Application:
63/061,205 →
Effects of Mescaline and of Mescaline Analogs (Scalines) to Assist Psychotherapy
Application:
63/153,318 →
Combination Product Using 3,4-Methylenedioxymethamphetamine and Carvedilol for the Treatment of Psychiatric Disorders
Application:
63/172,238 →